These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 21872946

  • 1. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M, Lourenço P, Dias C, Amorim M, Rema J, Leite AB, Guimarães JT, Almeida P, Bettencourt P.
    Int J Cardiol; 2013 Apr 30; 165(1):51-5. PubMed ID: 21872946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C.
    Acute Card Care; 2014 Sep 30; 16(3):93-101. PubMed ID: 24836558
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL.
    Circ Heart Fail; 2014 Jan 30; 7(1):35-42. PubMed ID: 24347663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
    Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ.
    Eur J Heart Fail; 2011 Aug 30; 13(8):846-51. PubMed ID: 21791540
    [Abstract] [Full Text] [Related]

  • 7. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S.
    Kidney Blood Press Res; 2009 Aug 30; 32(2):77-80. PubMed ID: 19287180
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
    Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL, George I, Farr MA, Mancini DM, Schulze PC.
    J Heart Lung Transplant; 2014 Dec 30; 33(12):1215-22. PubMed ID: 25049066
    [Abstract] [Full Text] [Related]

  • 9. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
    Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A.
    J Intern Med; 2012 May 30; 271(5):436-43. PubMed ID: 22211640
    [Abstract] [Full Text] [Related]

  • 10. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K, Littnerova S, Kubena P, Ganovska E, Pavlusova M, Kubkova L, Jarkovsky J, Pavkova Goldbergova M, Lipkova J, Gottwaldova J, Kala P, Toman O, Dastych M, Spinar J, Parenica J.
    BMJ Open; 2015 Oct 05; 5(10):e006872. PubMed ID: 26438132
    [Abstract] [Full Text] [Related]

  • 11. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N.
    Saudi J Kidney Dis Transpl; 2016 Jan 05; 27(1):49-54. PubMed ID: 26787566
    [Abstract] [Full Text] [Related]

  • 12. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, Magnusson NE.
    J Am Coll Cardiol; 2012 Jul 24; 60(4):339-45. PubMed ID: 22813613
    [Abstract] [Full Text] [Related]

  • 13. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B, Gaggin HK, Magrini L, Belcher A, Zancla B, Femia A, Simon M, Motiwala S, Bhardwaj A, Parry BA, Nagurney JT, Coudriou C, Legrand M, Sadoune M, Di Somma S, Januzzi JL, Global Research on Acute Conditions Team (GREAT).
    Clin Chem Lab Med; 2015 Mar 24; 53(4):613-21. PubMed ID: 25473804
    [Abstract] [Full Text] [Related]

  • 14. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S.
    Nephrology (Carlton); 2008 Apr 24; 13(2):153-6. PubMed ID: 18275504
    [Abstract] [Full Text] [Related]

  • 15. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
    Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH.
    J Card Fail; 2010 Jan 24; 16(1):49-54. PubMed ID: 20123318
    [Abstract] [Full Text] [Related]

  • 16. Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge.
    Ito M, Doi K, Takahashi M, Koyama K, Myojo M, Hosoya Y, Kiyosue A, Ando J, Noiri E, Yahagi N, Hirata Y, Komuro I.
    J Cardiol; 2016 Feb 24; 67(2):184-91. PubMed ID: 26228001
    [Abstract] [Full Text] [Related]

  • 17. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko JS.
    Transplant Proc; 2010 Jun 24; 42(5):1797-802. PubMed ID: 20620526
    [Abstract] [Full Text] [Related]

  • 18. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A, Beneke J, Menne J, Vetter F, Schmidt BM, Schiffer M, Haller H, Kümpers P, Kielstein JT.
    Thromb Haemost; 2014 Feb 24; 111(2):365-72. PubMed ID: 24172823
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction.
    Aberg F, Lempinen M, Hollmén M, Nordin A, Mäkisalo H, Isoniemi H.
    Clin Transplant; 2014 Aug 24; 28(8):869-76. PubMed ID: 24930480
    [Abstract] [Full Text] [Related]

  • 20. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME, Braam B, Diepenbroek A, van der Putten K, Cramer MJ, Wielders JP, Swinkels DW, Doevendans PA, Gaillard CA.
    Kidney Blood Press Res; 2012 Aug 24; 36(1):344-54. PubMed ID: 23235391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.